What is Kintor Pharmaceutical Limited?
Kintor Pharmaceutical Limited, a clinical-stage novel drug developer, focuses on developing small molecules and biologic drugs for dermatology and oncology in the People's Republic of China.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Kintor Pharmaceutical Limited, a clinical-stage novel drug developer, focuses on developing small molecules and biologic drugs for dermatology and oncology in the People's Republic of China. Its product candidates include KX-826, a potential topical drug for the treatment of androgenic alopecia (AGA) and acne vulgaris, which is in phase III clinical trial; and GT20029, a topical AR-PROTAC compound for the treatment of AGA and acne vulgaris that is in phase II clinical trial. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 183.95M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.